High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis

Clinica Chimica Acta

Volumn 413, Issue 23-24, 2012, Pages 1813-1816

  Villar, Luisa M ^a,b   Espiño, Mercedes ^a,b   Costa Frossard, Lucienne ^a,b   Muriel, Alfonso ^a,b   Jiménez, Juana ^c   Álvarez Cermeño, José C ^a,b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b INSTITUTO RAMÓN Y CAJAL DE INVESTIGACIÓN SANITARIA IRYCIS   (Spain)

^c HOSPITAL SEVERO OCHOA   (Spain)

Author keywords

Cerebrospinal fluid; Clinically isolated syndromes; Free kappa chains; Multiple sclerosis

Indexed keywords

IMMUNOGLOBULIN KAPPA CHAIN;

ACCURACY; ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL OUTCOME; COHORT ANALYSIS; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RISK; BLOOD; KAPLAN MEIER METHOD; PATHOLOGY; PROGNOSIS;

ADULT; FEMALE; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; KAPLAN-MEIER ESTIMATE; MALE; MULTIPLE SCLEROSIS; PROGNOSIS;

EID: 84864828115     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.07.007     Document Type: Article

References (16)

1. Polman, C.H., Reingold, S.C., Banwell, B., et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69 (2011), 292–302.
2. Freedman, M.S., Thompson, E.J., Deisenhammer, F., et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol 62 (2005), 865–870.
3. Masjuan, J., Álvarez-Cermeño, J.C., García-Barragán, N., et al. Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS. Neurology 66 (2006), 576–578.
4. Tintoré M., Rovira, A., Río, J., et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?. Neurology 70 (2008), 1079–1083.
5. Abraira, V., Álvarez-Cermeño, J.C., Arroyo, R., et al. Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice. J Immunol Methods 371 (2011), 170–173.
6. Shapiro, A.L., Scharff, M.D., Maizel, J.V., Uhr, J.W., Synthesis of excess light chains of gamma globulin by rabbit lymph node cells. Nature 211 (1966), 243–245.
7. Vakaet, A., Thompson, E.J., Free light chains in the cerebrospinal fluid: an indicator of recent immunological stimulation. J Neurol Neurosurg Psychiatry 48 (1985), 995–998.
8. Presslauer, S., Milosavljevic, D., Brücke, T., Bayer, P., Hübl, W., Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis. J Neurol 255 (2008), 1508–1514.
9. Poser, C.M., Paty, D.W., Scheinberg, L., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13 (1983), 227–231.
10. Fischer, C., Arneth, B., Koehler, J., Lotz, J., Lackner, K.J., Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis. Clin Chem 50 (2004), 1809–1813.
11. Fleiss, J.L., Statistical methods for rates and proportions, 2nd ed., 1981, John Wiley, New York, 38–46.
12. Barkhof, F., Filippi, M., Miller, D.H., et al. Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite MS. Brain 120 (1997), 2059–2069.
13. Rudick, R.A., French, C.A., Breton, D., Williams, G.W., Relative diagnostic value of cerebrospinal fluid kappa chains in MS: comparison with other immunoglobulin tests. Neurology 39 (1989), 964–968.
14. Kaplan, B., Aizenbud, B.M., Golderman, S., Yaskariev, R., Sela, B.-A., Free light chain monomers in the diagnosis of multiple sclerosis. J Neuroimmunol 229 (2010), 263–271.
15. Rudick, R.A., Jacobs, L., Kinkel, P.R., Kinkel, W.R., Isolated idiopathic optic neuritis. Analysis of free κ-light chains in cerebrospinal fluid and correlation with nuclear magnetic resonance findings. Arch Neurol 43 (1986), 456–458.
16. Rinker, J.R., Trinkkaus, K., Cross, A.H., Elevated CSF free kappa light chains correlate with disability prognosis in multiple sclerosis. Neurology 67 (2006), 1288–1290.